A Study to Investigate the Safety and Efficacy of KQB365 As Monotherapy and in Combination in Participants with Advanced Solid Malignancies
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-06
- Last Posted Date
- 2024-12-06
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 128
- Registration Number
- NCT06720987
A Study to Investigate the Safety and Efficacy of KQB198 As Monotherapy and in Combination in Participants with Advanced Hematologic Malignancies
- First Posted Date
- 2024-10-17
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 122
- Registration Number
- NCT06645886
- Locations
- ๐บ๐ธ
Colorado Blood Cancer Institute, Denver, Colorado, United States
๐บ๐ธOncology Hematology Cincinnati, Cincinnati, Ohio, United States
๐บ๐ธTexas Oncology Austin Central, Austin, Texas, United States
A Study to Investigate the Safety and Efficacy of KQB198 As Monotherapy and in Combination in Participants with Advanced Solid Malignancies
- First Posted Date
- 2024-07-18
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- Kumquat Biosciences Inc.
- Target Recruit Count
- 100
- Registration Number
- NCT06507306
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center, Long Island City, New York, United States
๐ช๐ธHospital Universitario Ramon y Cajal, Madrid, Spain
๐ช๐ธSTART Madrid - Hospital Fundacion Jimenez Diaz, Madrid, Spain
ยฉ Copyright 2024. All Rights Reserved by MedPath